Skip to Main content Skip to Navigation
Journal articles

Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group

Bruno Dubois 1, 2 Nicolas Villain 1, 2 Giovanni Frisoni 3 Gil Rabinovici 4 Marwan Sabbagh 5 Stefano Cappa 6 Alexandre Bejanin 7 Stéphanie Bombois 1, 8 Stéphane Epelbaum 1, 2, 9 Marc Teichmann 1 Marie-Odile Habert 10, 11 Agneta Nordberg 12 Kaj Blennow 13, 14 Douglas Galasko 15 Yaakov Stern 16 Christopher Rowe 17 Stephen Salloway 18 Lon Schneider 19 Jeffrey Cummings 5, 20 Howard Feldman 15
Abstract : In 2018, the US National Institute on Aging and the Alzheimer's Association proposed a purely biological definition of Alzheimer's disease that relies on biomarkers. Although the intended use of this framework was for research purposes, it has engendered debate and challenges regarding its use in everyday clinical practice. For instance, cognitively unimpaired individuals can have biomarker evidence of both amyloid β and tau pathology but will often not develop clinical manifestations in their lifetime. Furthermore, a positive Alzheimer's disease pattern of biomarkers can be observed in other brain diseases in which Alzheimer's disease pathology is present as a comorbidity. In this Personal View, the International Working Group presents what we consider to be the current limitations of biomarkers in the diagnosis of Alzheimer's disease and, on the basis of this evidence, we propose recommendations for how biomarkers should and should not be used for diagnosing Alzheimer's disease in a clinical setting. We recommend that Alzheimer's disease diagnosis be restricted to people who have positive biomarkers together with specific Alzheimer's disease phenotypes, whereas biomarker-positive cognitively unimpaired individuals should be considered only at-risk for progression to Alzheimer's disease.
Document type :
Journal articles
Complete list of metadata
Contributor : Gestionnaire Hal-Su <>
Submitted on : Wednesday, May 5, 2021 - 10:42:31 AM
Last modification on : Wednesday, May 12, 2021 - 7:19:31 PM


 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : 2021-10-29

Please log in to resquest access to the document



Bruno Dubois, Nicolas Villain, Giovanni Frisoni, Gil Rabinovici, Marwan Sabbagh, et al.. Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group. The Lancet Neurology, Elsevier, 2021, ⟨10.1016/S1474-4422(21)00066-1⟩. ⟨hal-03217875⟩



Record views